$3.61
-0.05-1.37%
Last update: Jun 17, 2:39 PM
Ironwood Pharmaceuticals Inc Earnings Estimates
IRWDNASDAQ
Ironwood Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:IRWD
Ironwood Pharmaceuticals (IRWD) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $0.27 and quarterly revenue of $118.04M.
In the most recent quarter (Q1), Ironwood Pharmaceuticals reported EPS of $0.24, beating estimates of $0.21 by 0.14%. Revenue came in at $106.51M, exceeding the estimate of $88.45M by 0.20%.
Over the last 4 quarters, Ironwood Pharmaceuticals has averaged an EPS surprise of 2.33% and a revenue surprise of 0.33%.
Earnings Date
Aug 6
EPS Estimate
$0.270
Quarterly Revenue Estimate
$118.04M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$361.51M
Ironwood Pharmaceuticals Earnings History
Analyze the earnings history of Ironwood Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Ironwood Pharmaceuticals (IRWD) Earnings Per Share
The chart below shows Ironwood Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Ironwood Pharmaceuticals (IRWD) Revenue
The chart below shows Ironwood Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Ironwood Pharmaceuticals (NASDAQ:IRWD) reporting earnings?
Ironwood Pharmaceuticals (IRWD) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Ironwood Pharmaceuticals (NASDAQ:IRWD)?
The Actual EPS was $0.24, which beat the estimate of $0.21.
What were Ironwood Pharmaceuticals’s (NASDAQ:IRWD) revenues?
The Actual Revenue was $106.51M, which beat the estimate of $88.45M.
